These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Postmenopausal osteoporosis: risk factors and possible therapies]. D'Amore M; Minenna G; D'Amore S Minerva Med; 2003 Jun; 94(3):141-55. PubMed ID: 14605595 [TBL] [Abstract][Full Text] [Related]
26. Treatment of postmenopausal osteoporosis. Liu AC N Engl J Med; 1998 Jul; 339(3):202; author reply 203. PubMed ID: 9669920 [No Abstract] [Full Text] [Related]
27. American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis. American Association of Clinical Endocrinologists Osteoporosis Task Force Endocr Pract; 2001; 7(4):293-312. PubMed ID: 11508261 [No Abstract] [Full Text] [Related]
28. [Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies]. Maeda T; Ke HZ; Simmons H; Thompson D Clin Calcium; 2004 Oct; 14(10):85-93. PubMed ID: 15577137 [TBL] [Abstract][Full Text] [Related]
29. [Osteoporosis in menopause: prevention and management]. Paran D; Elkayam O; Yaron M; Caspi D Harefuah; 1999 Mar; 136(6):483-8. PubMed ID: 10914269 [No Abstract] [Full Text] [Related]
30. [Treatment of osteoporosis with antiresorptive drugs]. Vestergaard P; Mosekilde L; Brixen K Ugeskr Laeger; 2005 Feb; 167(8):883-7. PubMed ID: 15789840 [No Abstract] [Full Text] [Related]
31. Early prevention vs late treatment for osteoporosis. Maricic M Arch Intern Med; 1997 Dec 8-22; 157(22):2545-6. PubMed ID: 9531221 [No Abstract] [Full Text] [Related]
32. [Treatment of osteoporosis]. Salmi J; Välimäki M Duodecim; 1996; 112(22):2131-8. PubMed ID: 10605219 [No Abstract] [Full Text] [Related]
33. [Estrogen replacement therapy in osteoporosis]. Hirvonen E Duodecim; 1996; 112(22):2123-9. PubMed ID: 10605218 [No Abstract] [Full Text] [Related]
34. A more active role for gynecologists in the prevention of postmenopausal osteoporosis. Ylikorkala O Gynecol Endocrinol; 2008 Jun; 24(6):293-4. PubMed ID: 18584406 [No Abstract] [Full Text] [Related]
35. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT. Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299 [TBL] [Abstract][Full Text] [Related]
36. [The successful development of bisphosphonates in the therapy of osteoporosis]. Fassbender WJ; Stumpf UC; Kurth A Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363 [TBL] [Abstract][Full Text] [Related]
37. Prevention and treatment of postmenopausal osteoporosis. National consensus of the "Belgian Bone Club"--September 1993. Clin Rheumatol; 1995 Sep; 14 Suppl 3():7-8. PubMed ID: 8846660 [No Abstract] [Full Text] [Related]
38. Bisphosphonate addition to stable hormone replacement therapy increases bone mineral density in postmenopausal women. Boulos P; Sebaldt RJ; Goldsmith CH J Rheumatol; 2002 May; 29(5):1110-1. PubMed ID: 12022339 [No Abstract] [Full Text] [Related]
39. Prevention and treatment of postmenopausal osteoporosis. Lewiecki EM Obstet Gynecol Clin North Am; 2008 Jun; 35(2):301-15, ix. PubMed ID: 18486843 [TBL] [Abstract][Full Text] [Related]
40. Oral contraceptive use in osteoporosis. Khoyi AA; Middleton RK Ann Pharmacother; 1992 Sep; 26(9):1094-5. PubMed ID: 1421674 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]